|
Market Closed -
Nasdaq
01:30:00 27/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.470 USD | -0.46% |
|
+2.86% | -46.71% |
| 24/10 | Ocular Therapeutix, Inc. - Special Call | |
| 20/10 | Ocular Therapeutix Has 75% Success Probability for Axpaxli in Wet Age-Related Macular Degeneration, UBS Says | MT |
| Market Cap | 142.09Cr 127.06Cr 117.55Cr 106.43Cr 199.2Cr 14TCr 202.47Cr 1.41TCr 559.54Cr 7.07TCr 533.3Cr 521.9Cr 22TCr | P/E 2026 * |
-4.34x | P/E 2027 * | -4.58x |
|---|---|---|---|---|---|
| Enterprise Value | 100Cr 89Cr 82Cr 75Cr 139.6Cr 9.47TCr 141.89Cr 991.35Cr 392.14Cr 4.96TCr 373.74Cr 365.76Cr 16TCr | EV / Sales 2026 * |
18.8x | EV / Sales 2027 * | 11.7x |
| Free-Float |
99.09% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCUL | Delayed | |
CBOE
| OCUL | Real-time | |
|
Tradegate
| 0OT | Real-time | |
|
Boerse Muenchen
| 0OT | Real-time | |
|
Deutsche Boerse AG
| 0OT | Delayed | |
|
Börse Stuttgart
| 0OT | Delayed | |
|
Berne S.E.
| 0OT | End-of-day quote |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | -0.46% | ||
| 1 week | +2.86% | ||
| Current month | -15.65% | ||
| 1 month | -32.95% | ||
| 3 months | -23.93% | ||
| 6 months | -31.82% | ||
| Current year | -46.71% |
| 1 week | 6.34 |  | 6.75 |
| 1 month | 6 | | 9.38 |
| Current year | 6 | | 13.03 |
| 1 year | 6 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 20/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Sell | General Counsel | -11,984 | 0.0057% | ||
| 02/10/26 | Sell | Executive/Senior Manager | -9,990 | 0.0047% | ||
| 02/10/26 | Sell | Chief Technology Officer | -10,869 | 0.0051% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | +2.86% | -43.69% | +163.01% | 142.09Cr | |
| +0.45% | +3.13% | +54.96% | +125.16% | 1,14000Cr | |
| +0.94% | +4.93% | +39.86% | +78.72% | 64TCr | |
| +0.39% | +1.44% | +25.77% | +97.48% | 51TCr | |
| +0.03% | +1.69% | +48.28% | +66.77% | 38TCr | |
| -3.21% | -2.10% | +60.72% | +33.22% | 35TCr | |
| +0.56% | +2.28% | +25.42% | +54.47% | 29TCr | |
| -0.23% | +1.89% | +2.47% | +26.99% | 27TCr | |
| +1.22% | +4.63% | +52.40% | +64.85% | 24TCr | |
| +1.70% | +3.67% | +31.21% | +102.15% | 20TCr | |
| Average | +0.33% | +2.92% | +29.74% | +81.28% | 40.15TCr | |
| Weighted average by Cap. | +0.30% | +2.98% | +41.74% | +84.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.28Cr 4.72Cr 4.37Cr 3.96Cr 7.41Cr 502.68Cr 7.53Cr 53Cr 21Cr 262.92Cr 20Cr 19Cr 832.47Cr | 10Cr 9.12Cr 8.44Cr 7.64Cr 14Cr 970.84Cr 15Cr 101.59Cr 40Cr 507.78Cr 38Cr 37Cr 1.61TCr |
| Net income | -33Cr -30Cr -28Cr -25Cr -47Cr -3.18TCr -48Cr -332.72Cr -131.61Cr -1.66TCr -125.44Cr -122.76Cr -5.27TCr | -33Cr -30Cr -27Cr -25Cr -46Cr -3.14TCr -47Cr -328.91Cr -130.1Cr -1.64TCr -124Cr -121.35Cr -5.21TCr |
| Net Debt | -43Cr -38Cr -35Cr -32Cr -60Cr -4.04TCr -61Cr -423.22Cr -167.41Cr -2.12TCr -159.55Cr -156.15Cr -6.7TCr | -22Cr -20Cr -19Cr -17Cr -32Cr -2.14TCr -32Cr -223.73Cr -89Cr -1.12TCr -84Cr -83Cr -3.54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | $6.470 | -0.46% | 16,90,500 |
| 23/26/23 | $6.500 | -1.66% | 18,55,969 |
| 22/26/22 | $6.610 | +2.01% | 21,45,011 |
| 21/26/21 | $6.480 | -2.56% | 24,91,836 |
| 20/26/20 | $6.650 | +5.72% | 26,17,323 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
